Skip to main content
Dennis Cooper, MD, Oncology, New Brunswick, NJ, Robert Wood Johnson University Hospital

DennisLCooperMD

Oncology New Brunswick, NJ

Hematologic Oncology

Professor of Medicine, Yale University

Dr. Cooper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cooper's full profile

Already have an account?

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1982 - 1983
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1979 - 1982
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1979
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Medical Oncology

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2022 - 2026
  • CT State Medical License
    CT State Medical License 1981 - 2025
  • NJ State Medical License
    NJ State Medical License 2015 - 2023
  • PA State Medical License
    PA State Medical License 1982 - 1984
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Narcotic Use in Multiple Myeloma Patients at the Time of ASCT and One-Year Follow up
    Dennis Cooper, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Incorporation of Posttransplant Cyclophosphamide (PCy) As Part of Standard Immunoprophylaxis (IP) for All Allogeneic Transplants: A Retrospective, Single Institution S... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Hospital Affiliations